💡 50% of hires happen without a job posting·⚡ Apply spontaneously to dozens of companies·📈 Track opens & CV clicks

Cellistic

Public profile

Mont-Saint-Guibert, BE
51-200 collaborators
- Pharmaceutical/Biotech
- and 1 others
  Hospital and health care

Mont-Saint-Guibert, BE
51-200 collaborators
- Pharmaceutical/Biotech
- and 1 others
  Hospital and health care

Overview Cellistic

https://www.cellistic.com/

Recruitment status:Company to discover — The information displayed comes from public data and may include approximations. The company may not currently be hiring, but you can apply proactively to share your profile.

Pharmaceutical/Biotech
Hospital and health care

Mont-Saint-Guibert
51-200 collaborators

About us

What we do: Cellistic specializes in the development and manufacturing of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company offers proprietary platforms, Pulse™ for cell line development and Echo™ for cell therapy manufacturing, enabling scalable, cost-effective production of allogeneic off-the-shelf cell therapies. Cellistic partners with innovative cell therapy developers to accelerate the translation of novel advanced therapies into clinical applications, focusing on immune cell types such as NK cells and various T cells.

Where we are located: Cellistic is headquartered in Mont-Saint-Guibert, Belgium, at Rue Edouard Belin 2, 1435.

Short history: Founded in April 2022 as a subsidiary of Ncardia, Cellistic leverages over a decade of scientific and technical expertise transferred from its sister company. Since its inception, the company has developed groundbreaking iPSC-based platforms and launched innovative products such as the Allo Chassis™ immune-cloaked iPSC cell lines, advancing the accessibility and scalability of cell therapies.

Organization & culture: Cellistic is a growing company with approximately 60 employees. It fosters a culture of innovation and collaboration, driven by a multidisciplinary team of experts in stem cell biology, gene editing, and bioprocess development. The company values scientific excellence and aims to make transformative cell therapies accessible worldwide.

Recent developments: In 2025, Cellistic appointed Tarran Pierfelice, PhD, MBA as Chief Commercial Officer, strengthening its leadership team. The company also announced the launch of its Allo Chassis™ immune-cloaked iPSC cell lines, designed to reduce development timelines and costs while maintaining GMP standards. Cellistic actively participates in international events such as BIO 2025 to showcase its technology and foster partnerships.

Company roles mapping

This mapping combines roles declared by the company and roles identified by artificial intelligence from public data or past job offers. Some job titles are also standardised according to the European ESCO nomenclature (European Skills, Competences, Qualifications and Occupations) to ensure consistency with European skills frameworks. Learn more about AI transparency and ESCO →